FDA NDC Directory · JSON-LD · Markdown

Dupixent

NDC 0024-5915 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameDupilumab
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA761055
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsDUPILUMAB (300 mg/2mL)
Marketing started20200619
Package count2

External sources

Source: openFDA. Public-domain (CC0).